253 related articles for article (PubMed ID: 25055196)
1. Intracellular delivery of antisense peptide nucleic acid by fluorescent mesoporous silica nanoparticles.
Ma X; Devi G; Qu Q; Toh DF; Chen G; Zhao Y
Bioconjug Chem; 2014 Aug; 25(8):1412-20. PubMed ID: 25055196
[TBL] [Abstract][Full Text] [Related]
2. Cellular delivery and antisense effects of peptide nucleic acid conjugated to polyethyleneimine via disulfide linkers.
Berthold PR; Shiraishi T; Nielsen PE
Bioconjug Chem; 2010 Oct; 21(10):1933-8. PubMed ID: 20873710
[TBL] [Abstract][Full Text] [Related]
3. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
4. Cellular Antisense Activity of PNA-Oligo(bicycloguanidinium) Conjugates Forming Self-Assembled Nanoaggregates.
Valero J; Shiraishi T; de Mendoza J; Nielsen PE
Chembiochem; 2015 Jul; 16(11):1593-600. PubMed ID: 26010253
[TBL] [Abstract][Full Text] [Related]
5. Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma.
Jia F; Balaji BS; Gallazzi F; Lewis MR
Nucl Med Biol; 2015 Nov; 42(11):809-15. PubMed ID: 26239085
[TBL] [Abstract][Full Text] [Related]
6. In situ tracking the intracellular delivery of antisense oligonucleotides by fluorescein doped silica nanoparticles.
Zhang P; Wang TY; Xiong HM; Kong JL
Talanta; 2014 Sep; 127():43-50. PubMed ID: 24913855
[TBL] [Abstract][Full Text] [Related]
7. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
[TBL] [Abstract][Full Text] [Related]
8. Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system.
Mortera R; Vivero-Escoto J; Slowing II; Garrone E; Onida B; Lin VS
Chem Commun (Camb); 2009 Jun; (22):3219-21. PubMed ID: 19587919
[TBL] [Abstract][Full Text] [Related]
9. Peptide nucleic acid Pt(II) conjugates: a preliminary study of antisense effects in Xenopus laevis.
Dodd DW; Damjanovski S; Hudson RE
Nucleosides Nucleotides Nucleic Acids; 2011 Apr; 30(4):257-63. PubMed ID: 21623539
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
Gallazzi F; Wang Y; Jia F; Shenoy N; Landon LA; Hannink M; Lever SZ; Lewis MR
Bioconjug Chem; 2003; 14(6):1083-95. PubMed ID: 14624621
[TBL] [Abstract][Full Text] [Related]
11. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates.
Kaihatsu K; Huffman KE; Corey DR
Biochemistry; 2004 Nov; 43(45):14340-7. PubMed ID: 15533038
[TBL] [Abstract][Full Text] [Related]
12. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
[TBL] [Abstract][Full Text] [Related]
13. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.
Xia T; Kovochich M; Liong M; Meng H; Kabehie S; George S; Zink JI; Nel AE
ACS Nano; 2009 Oct; 3(10):3273-86. PubMed ID: 19739605
[TBL] [Abstract][Full Text] [Related]
14. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G
J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
[TBL] [Abstract][Full Text] [Related]
17. Flavin conjugates for delivery of peptide nucleic acids.
Marlin F; Simon P; Bonneau S; Alberti P; Cordier C; Boix C; Perrouault L; Fossey A; Saison-Behmoaras T; Fontecave M; Giovannangeli C
Chembiochem; 2012 Nov; 13(17):2593-8. PubMed ID: 23129496
[TBL] [Abstract][Full Text] [Related]
18. Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers.
Shiraishi T; Nielsen PE
Artif DNA PNA XNA; 2011; 2(3):90-9. PubMed ID: 22567192
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
20. Effective photo-enhancement of cellular activity of fluorophore-octaarginine antisense PNA conjugates correlates with singlet oxygen formation, endosomal escape and chromophore lipophilicity.
Yarani R; Shiraishi T; Nielsen PE
Sci Rep; 2018 Jan; 8(1):638. PubMed ID: 29330463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
